Clinical Research Directory

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Sponsor: Takeda

Summary

This study is a survey in Japan of Brigatinib tablets used to treat Japanese people with non-small cell lung cancer. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. The main aim of the study is to check for side effects related to lung disease from Brigatinib. During the study, participants with non-small cell lung cancer will take Brigatinib tablets according to their clinic's standard practice. The study doctors will check for side effects from Brigatinib for 1 year.

Official title: General Use-results Survey of Alunbrig Tablets "Non-small Cell Lung Cancer"

Key Details

Conditions

Interventions

Locations (1)